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Recently, one of the PDZ domains in the cytosolic 
protein-tyrosine phosphatase Fas-associated phospha­
tase-1 (FAP-l)/protein-tyrosine phosphatase-BAS (PTP- 
BAS) was shown to interact with the carboxyl-terminal 
¿S-L-V peptide of the human Fas receptor (Sato, T., Irie, 
S., Kitada, S., and Reed, J. C. (1995) Science 268, 411- 
415), suggesting a role for protein (de)phosphorylation 
in Fas signaling. To investigate whether this interaction 
is conserved in mouse, we performed yeast two-hybrid 
interaction experiments and transfection studies in 
mouse T cell lines. For the corresponding PDZ motif in 
the mouse homologue of FAP-1/PTP-BAS, protein-tyro- 
sine phosphat as e-BAS-like (PTP-BL), only an interac­
tion with human but not with mouse Fas could be de­
tected. Presence of the fS-L-V motif proper, which is 
unique for human Fas, rather than the structural con­
text of its carboxyl terminus, apparently explains the 
initially observed binding. To test for functional conser­
vation of any indirect involvement of PTP-BL in Fas- 
mediated signaling, we generated T lymphoma cell lines 
stably expressing mouse or human Fas receptor with 
and without PTP-BL. No inhibitory effect of PTP-BL was 
observed upon triggering apoptosis using mouse or hu­
man Fas-activating antibodies. Together with the mark­
edly different tissue expression patterns for PTP-BL 
and Fas receptor, our findings suggest that protein-ty­
rosine phosphatase PTP-BL does not play a key role in 
the Fas-mediated death pathway.
Many signaling pathways depend upon the reversible assem­
bly of protein complexes to evoke temporally and spatially 
distinct effects. Small modular protein domains like Src homol­
ogy 2 (SH2) and SH3 domains and phospho tyrosine-binding 
domains, were found to play an important role in signal trans­
duction cascades (1-3). Recently, it has become clear th a t PDZ 
motifs have a similar role (4). PDZ motifs (acronym for postsyn- 
aptic density protein PSD-95, Drosophila discs-large tumor 
suppressor DlgA, and the tight junction protein ZO-1) are now 
identified in a wide variety of proteins in bacteria (5) and lower 
and higher eukaryotes (6), many of which are localized at 
specific regions of cell-cell contact, such as tight, septate, and 
synaptic junctions (7). For example, PDZ motifs present in
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membrane-associated guanylate kinase family members have 
been found to interact with the carboxyl terminus of diverse 
transm em brane proteins (8), thereby inducing clustering of 
these proteins at specialized cell-cell junctions (9). Recent ex­
periments demonstrate th a t PDZ motifs from different types of 
proteins can recognize unique carboxyl-terminal peptide motifs 
(10-12), As these interactions have been identified by screen­
ings of peptide libraries, the in vivo relevance for most of them 
remains to be demonstrated. PTP-BAS (13), also known as 
hPTPlE  (14) and PTPL1 (15) in  hum ans, is one of the few 
PDZ-containing proteins known so far th a t contain an active 
catalytic protein domain, i.e. a carboxyl-terminal protein-ty­
rosine phosphatase domain, Recently, th is protein was found to 
directly associate via one of its PDZ motifs to the carboxyl- 
term inal regulatory domain of Fas and was termed FAP-11 for 
Fas-as so da ting  phosphat as e-1 (16). This association points to a 
possible link between reversible tyrosine phosphorylation and 
the apoptotic death cascade mediated by Fas. Activation of the 
Fas receptor (17), a member of the tum or necrosis factor recep­
tor superfamily (18), induces very rapid physiological and mor­
phological changes in many cell types (19). The Fas receptor 
itself does not contain a catalytic protein domain, but in the 
activated conformation it  recruits several proteins to the death- 
inducing signaling complex (20), which can trigger several pro­
teolytic cascades and signaling pathways (21), Direct associa­
tion of a protein-tyrosine phosphatase could have im portant 
modulatory effects on Fas signaling, and indeed a correlation 
between FAP-1 expression and (partial) resistance to Fas-me­
diated apoptosis has been noted in the hum an system (16).
The second PDZ motif of the five PDZ motifs as present in 
FAP-1 (referred to as the th ird  out of six PDZ motifs in Refs. 16 
and 10) and the carboxyl-terminal 15 amino acids of Fas were 
found to be necessary and sufficient for the observed direct 
association between FAP-1 and Fas (16). Indeed, screenings of 
oriented peptide libraries employing the second PDZ motif of 
FAP-1 revealed a consensus binding sequence of £(S/T)-X-(V/ 
I/L) (10, 12) th a t is present in  the Fas carboxyl terminus
(fS-L-V).
Puzzled by the considerable sequence divergence displayed 
by the carboxyl term inus of Fas (Fig. 1), we set out to study 
whether FAP-1’s presumed role in Fas signaling was evolution­
ary conserved. We found th a t mouse Fas does not interact with 
the mouse homologue of PTP-BAS/FAP-1, known as PTP-BL 
(22) or RIP (23). Furtherm ore, studies using transformed 
mouse cell lines failed to dem onstrate any role for PTP-BL in
1 The abbreviations used are: FAP-1, Fas-associated phosphatase-1; 
PTP-BAS, protein-tyrosine phosphatase-BAS; PTP-BL, protein-tyro­
sine phosphatase-BAS-like; £, carboxyl-terminal peptide; PBS, phos­
phat e-buffered saline.
This paper is available on line at http://www.jbc.org 30215
3 0 2 1 6 PTP-BL and FAS-mediated Apoptosis
the regulation of Fas-mediated signaling. Our results show 
that the interaction between the Fas receptor and PTP-BL is 
not conserved between mice and men.
EXPERIMENTAL PROCEDURES
Two-hybrid Interaction Trap—Plasmid DNAs and the yeast strain 
used for the interaction trap assay were provided by Dr, Roger Brent 
and colleagues (Massachusetts General Hospital, Boston) and used as 
described (24). The individual PDZ motifs of PTP-BL were cloned in the 
pEG202 bait vector by amplifying PTP-BL sequences using specific 
primers containing convenient restriction sites for cloning purposes. 
This results in LexA fusion proteins containing amino acids 1076-1177 
(BL-PDZ-I), 1352-1450 (BL-PDZ-II), 1471-1601 (BL-PDZ-III), 1756- 
1855 (BL-PDZ-IV), and 1853-1946 (BL-PDZ-V) of PTP-BL. The carbox­
yl-terminal 60 residues of mouse Fas were cloned in the prey vector 
pJGBr2 by subcloning a 599-base pair Pvull-Dral restriction fragment 
from pBOS-EA (25), and for the human Fas carboxyl terminus (40 
amino acids)» this was done by subcloning a 120-base pair Bglll-Apal 
restriction fragment from pCMV-hFAS (a kind gift of Dr. Anderson, 
Cambridge, MA). Construction of the control baits is described else­
where2 (11). Two-hybrid interactions were analyzed by plating yeast 
containing reporter, bait, and prey constructs on minimal medium agar 
plates containing 5-bvomo-4- chloro- 3-indolyl- fkn-galactopyx anoside 
and lacking tryptophan, histidine, uracil, and leucine and subsequent 
incubation at 30 °C for 4 days.
The relative strength of two-hybrid interactions was determined by 
measuring the /3-galactosidase activity in crude yeast lysates. For this, 
a single yeast colony was inoculated in 1.5 ml of minimal medium 
lacking histidine, tryptophan, and uracil and containing 2% galactose 
and 1% raffmose. After overnight growth at 30 °C until the culture 
reached Asoo nm «1 .0 , the cells were pelleted and resuspended in 0.2 ml 
of ice-cold buffer (0.1 M NaCl, 10 m M  Tris-HCl, pH 7*0, 1 m M  EDTA, 1 
mM phenylmethylsulfonyl fluoride). About 100 p\ of acid-washed glass 
beads (425-600 Sigma) were added, and the suspension was vor- 
texed six times for 30 s alternated with 30-s incubations on ice. Lysates 
were centrifuged for 5 min with 14,000 rpm at 4 °C. Supernatants were 
transferred to fresh Lubes and used for protein concentration determi­
nation (26). j3-Galactosidase activity was measured by adding 10 jul of 
lysate to 200 /¿I of freshly prepared ONPG buffer (100 m M  phosphate 
buffer, pH 7.0,1 m M  MgCl, 10 m M  KC1, 50 m M  j3-mercaptoethanol, 0,35 
mg/ml o - n itro p h e n y l- 0 - D - g a la c to p yra n o s id e  (Sigma)) in microtiter 
plates. Reactions were incubated at 30 °C and the A420 nm was moni­
tored for 1 h on a CERES UV900C MTP-photometer (Bio-Tek). The 
sp e c ific  /3-galactosidase activity (arbitrary units) was calculated using 
the initial linear part of the A420 nm/min curves and normalized for the 
protein concentration in the sample. Every sample was measured in 
duplicate, and for each bait-prey combination, five independent colonies 
were assayed.
Cell Lines and Cell Culture—Mouse T cell lymphoma WR19L cell line 
(ATCC TIB52) was grown in RPMI 1640 medium containing 10% fetal 
calf serum. Transformants expressing mouse or human Fas and 
PTP-BL were established by electroporation as described (17). Briefly,
1 X  107 WR19L cells in  0.5 ml of K-PBS (30.8 m M  NaCl, 120.7 m M  KC1, 
8.1 m M  Na2P 04, 1.46 m M  KH2P04) were cotransfected with 2.5 jig/ml 
Puul linearized pcDNA3 (Invitrogen) or pcDNA-BL (full-length PTP-BL 
cDNA (22) cloned in pcDNA3) and 25 jug/ml VspI linearized pEF-F58 
(17) or pBOS-EA (25) by electroporation at 290 V with a capacitance of 
960 /xF using a Gene Pulser (Bio-Rad). Cells were cultured in 40 ml of 
RPMI, 10% fetal calf serum in 96-well microtiter plates (0.1 ml/well) for
2 days, and neomycin-resistant clones were then selected in medium 
containing G418 (900 /Ag/ml). Cells were analyzed for PTP-BL and Fas 
receptor expression after 14 days of selection.
Western Blot Detection of PTP-BL—WR19L or derived transformed 
cells were lysed in buffer (10 m M  Tris-HCl, pH 8.0,150 m M  NaCl, 5 m M  
EDTA, 0.5% Nonidet P-40) for 1 h on ice and centrifuged for 10 min at 
10,000 X g. Amounts of lysate containing 25 (xg of protein were loaded 
in each lane of a 4% (w/v) polyacrylamide mini-gel (Bio-Rad), and 
following electrophoresis, proteins were blotted onto nitrocellulose (Am- 
ersham Corp.). The blot was blocked for 30 min in 5% non-fat dry milk 
in PBST (PBS containing 0.05% Tween 20) and subsequently incubated 
for 1 h with affinity-purified polyclonal antibody directed against the 
carboxyl-terminal catalytic PTPase domain of PTP-BL2 in a one to 
thousand dilution in PBST containing 1% normal goat serum. After 
subsequent washings, the blot was incubated for 1 h with peroxidase-
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F ig . 1. Sequence comparison of the Fas recep to r carboxyl te r­
m inus from  different species. The last 9 amino acids of human 
(accession number M67454), mouse (accession number A46484), rat 
(accession number JC2395), and bovine Fas receptor (accession number 
U34794) are shown and aligned with the proposed PDZ binding motif 
¿(T/S)-X-V (asterisks indicate the carboxyl terminus).
conjugated goat anti-rabbit (20.000 X diluted, Pierce), washed, and 
labeled bands were visualized using chemiluminescent substrate 
(Pierce) according to the manufacturer’s instructions.
Flow Cytofluorometric Analysis of Surface-bound Fas Receptor—Ex- 
pression of Fas antigen was analyzed by incubating 5 X 105 cells in 100 
jLtl of IF buffer (PBS, 1% bovine serum albumin, 0.1% sodium azide) 
containing 0.5 jug/ml hamster monoclonal antibody Jo2 (27) for detec­
tion of mouse Fas or mouse monoclonal antibody CH-11 (28) for detec­
tion of human Fas, for 30 min on ice. The cells were washed twice with 
IF buffer and incubated with fluorescein isothiocyanate-conjugated 
goat a-hamster-Ig (Jackson ImmunoResearch, diluted 1:25 in IF buffer) 
or fluorescein isothiocyanate-conjugated Rabbit a-mouse-Ig (Dako, di­
luted 1:50 in IF buffer). Cells were washed and resuspendend in 0.5 ml 
of IF buffer and analyzed on a flow cytofluorometer (Coulter).
Assay for Apoptotic Response—Mouse WR19L wild type or trans­
formed cells were seeded at 1 X 105 cells/ml in a 24-well tissue culture 
plate and cultured at 37 °C. Cell death was induced by addition of 
anti-Fas monoclonal antibody (Jo2 for mouse Fas or CH-11 for human 
Fas expressing cells) to a final concentration ranging from 10~9 to 1G-3 
mg/ml. After incubation at 37 °C for 1 to 20 h, dead cells were stained 
by adding propidium iodine to a final concentration of 4 /xg/ml and 
incubating at room temperature for 10 min. The percentage of dead 
cells was determined by flow cytofluorometric analysis (Coulter).
Northern Blotting—Total RNA from several tissues was prepared 
using the guanidium isothiocy at e-phenol-chloroform extraction method 
(29), 15 ju,g of RNA was loaded on a 1% formamide agarose gel, and after 
electrophoresis the RNA was transferred to nylon membrane according 
to standard procedures (30). Complete PTP-BL (22) and mouse Fas (25) 
cDNAs were radioactively labeled by random priming and used as 
probes for hybridization.
RESULTS
No In teraction  between Mouse Fas Receptor and PTP-BL— 
The large difference between species th a t is obvious in the 
carboxyl-terminal Fas receptor sequence (Fig. 1) prompted us 
to test the interaction between Fas receptor and PTP-BL using 
the two-hybrid interaction trap (24). Baits were generated con­
taining either the complete array of PDZ motifs or individual 
PDZ motifs of PTP-BL and were assayed for interaction with 
both mouse and human Fas carboxyl termini. An interaction of 
the ensemble of five PDZ motifs of PTP-BL (BL-PDZ-I-V) with 
the hum an Fas receptor could be observed, but no interaction 
occurred with mouse Fas receptor (Fig. 2). Assays employing 
single PDZ motifs only revealed an interaction for BL-PDZ-II 
and hum an Fas receptor, but this was ra ther weak. No inter­
action of mouse Fas receptor with any of the PTP-BL PDZ 
motifs tested was observed, nor did any of the baits activate 
transcription of the /3-galactosidase reporter in the presence of 
an empty prey vector (Fig. 1).
Finally, two nonrelated domains, the nNOS PDZ motif, 
found to recognize the carboxyl-terminal ¿G-(D/E)-X-V motif 
(11, 31), and the RIL PDZ motif,2 did not interact with mouse 
or hum an Fas receptor. Another motif, the second PDZ motif of 
PSD95/SAP90, known to recognize £(T/S)-X-V (32, 33), did in­
teract only with the human Fas receptor (not shown, Ref 11).
Generation o f  Stable PTP-BL and Fas Transform ants—To 
study any functional involvement of PTP-BL in Fas-mediated 
apoptosis, we generated stable transformants of the mouse T 
cell lymphoma WR19L cell line. This cell line does not express 
PTP-BL (Fig. 3 C) or endogenous Fas receptor as identical flow
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Fig. 2. Two-hybrid analysis of the in teraction between 
PT P-B L  PDZ motifs and the  carboxyl term inus of mouse and  
h u m a n  Fas receptor. A, schematic overview of the domain structure 
of PTP-BL and the protein domains used for the two-hybrid interaction 
analysis. B} 5“bromo-4-chloro-3-indolyl-/3-D-galactopyranoside assay 
plate for a two-hybrid interaction in yeast between PTP-BL PDZ motifs 
as baits and mouse or human Fas receptor carboxyl termini as prey. C, 
semi-quantitative analysis of the interaction strength between different 
PDZ motifs and mouse and human Fas receptor carboxyl termini using 
the two-hybrid interaction trap. The interaction strength for mouse Fas 
receptor (black bar), human Fas receptor {gray bar), and empty prey 
vector (open bar) as a control, with the various PDZ baits, were deter­
mined by measuring the /3-galactosidase activity in crude yeast lysates. 
Error bars indicate the standard deviation (n = 5).
cytometric staining profiles were obtained with (Fig. 3A) and 
w ithout the primary anti-Fas antibody (not shown). Expression 
plasm ids were introduced by electroporation and protein ex­
pression of Fas receptor and PTP-BL were analyzed by flow 
cytofluorometric analysis and Western blotting, respectively. 
No endogenous Fas receptor could be detected in the wild type 
WR19L cell line. Stable transform ants were obtained express­
ing hum an Fas receptor in combination with (H20 and H25) or 
w ithout (4B1) PTP-BL (Fig. 3, A  and C). Similarly transfor­
m an ts  were generated expressing mouse Fas receptor with (M3
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Fig. 3. C h arac te riza tio n  of transfo rm ed  WR19L cells. Surface 
expression of human Fas receptor (A) and mouse Fas receptor (B ) in 
WR19L transformants was detected using specific monoclonal antibod­
ies and analyzed by flow cytofluorometry. PTP-BL expression in the 
transformants was analyzed by Western blotting (C). Equal amounts of 
protein from total lysates were loaded on a 4% polyacrylamide gel, 
blotted, and PTP-BL was detected using an affinity-purified polyclonal 
antiserum (a-BL-PTP). Absence (—) or presence (+) of PTP-BL, mouse, 
and human Fas receptor in the different transformants is indicated at 
the bottom.
and M5) or without (2H2) PTP-BL (Fig. 3, B  and C). In addition 
a control line expressing PTP-BL only was generated (3G) (Fig, 
3, B  and C). Transform ants H 20, H25 and M3, M5 express 
about equal amounts of surface-bound Fas receptor, as meas­
ured by flow cytofluorometric analysis (Fig. 3, A and B), but 
express different amounts of PTP-BL as determined by West­
ern blotting (Fig. SC).
Time Response to A ntibody-induced  Fas-m ediated Apopto­
sis —Apoptosis was triggered in  the hum an Fas receptor trans­
formants by adding monoclonal anti-Fas IgM (CH-11, 250 ng/ 
ml), and apoptosis was m easured at fixed time points by 
propidium iodine uptake and flow cytofluorometric analysis. As 
expected, the wild type cell line WR19L and the transform ant 
th a t expresses PTP-BL only (3C), which both lack Fas receptor
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Fig. 4. Time response cu rve  of WH19L transfo rm ants upon 
antibody-induced Fas-m ediated  apoptosis. Apoptosis mediated by 
the human Fas receptor (A) or the mouse Fas receptor (5) was induced, 
by adding the monoclonal antibody CH-ll (250 ng/ml) or Jo2 (250 
ng/ml), respectively. At fixed time points cells were withdrawn, and 
dead cells were stained by propidium iodine uptake and analyzed by 
flow cytofluorometry.
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Fig, 5. P ose  response of WR19L transfo rm ants for antibody- 
induced Fas-m ediated apoptosis. Apoptosis was induced in WR19L 
transformants expressing human Fas receptor (A) and mouse Fas re­
ceptor CB) by adding increasing amounts of monoclonal antibody (final 
concentration ranging from 10“9 to I0 “a mg/ml). After 20 h dead cells 
were stained by propidium iodine uptake and analyzed by flow 
cytofluorometry.
expression, do not undergo antibody-induced apoptosis (Fig. 4, 
A  and B). The hum an Fas receptor-expressing transform ant 
(4B1) undergoes rapid apoptosis, and within 8 h over 95% of the 
cells have permeable membranes and take up propidium io­
dine, indicative for the onset of apoptosis. The transformants 
expressing in addition PTP-BL (H20 and H25) undergo rapid 
apoptosis also, although a t a slightly slower pace. However, cell 
lines with and without PTP-BL are indistinguishable when the 
time points at 20-h incubation are compared. Furthermore, no 
influence of the amount of PTP-BL protein expression is ob­
served (H20 versus H25, Fig. 4A). These results indicate tha t 
PTP-BL expression has no major influence on human Fas- 
mediated apoptosis in mouse WR19L cells and doesn’t  protect 
against apoptosis.
A similar experiment was done with the mouse Fas receptor 
transformants by triggering apoptosis with the monoclonal an­
tibody Jo2 (anti-mouse Fas). Apoptosis in the cell line express­
ing only mouse Fas receptor (2H2) is somewhat slower com­
pared with hum an Fas-mediated apoptosis. This difference 
may be explained by the lower surface expression of the mouse 
Fas receptor on 2H2 (Fig. 35) or may be due to clonal variations 
or subtle differences in the way these two monoclonal antibod­
ies induce apoptosis.
Compared w ith the cell line expressing only mouse Fas re­
ceptor (2H2), the transform ants th a t express PTP-BL as well 
as mouse Fas receptor (M3 and M5) undergo apoptosis more 
rapidly (Fig. 4jB), bu t a t a  ra te  comparable with the hum an
Fas-mediated apoptosis (Fig. 4A). Again, comparison of the 
read-out upon overnight incubation of the transformants with 
apoptosis inducing antibody revealed no effect of PTP-BL at all. 
Taken together these findings indicate th a t PTP-BL expression 
is not a significant modulatory factor in mouse or human Fas- 
mediated apoptosis.
Dose Response to Antibody-induced Fas-mediated Apopto­
s is —Perhaps the impact of PTP-BL on Fas-mediated apoptosis 
is much more subtle than what was proposed for the human 
counterpart. Therefore, we tested for the influence of PTP-BL 
expression on dose responsiveness by treating wild type 
WR19L cells and its transformants overnight with increasing 
amounts of apoptosis inducing antibody. Even at the highest 
concentration of antibody tested, cells without Fas receptor are 
refractory to undergo apoptosis (Fig. 5, A  and B ). The dose-de­
pendent sensitivity for Fas-mediated apoptosis did not signifi­
cantly differ between Fas receptor transform ants with and 
without PTP-BL. Again, this argues against an inhibiting role 
of PTP-BL in  Fas signaling. Moreover, the mouse Fas receptor 
expressing transformant seems to be slightly less sensitive 
without PTP-BL expression, even suggesting a small apoptosis- 
enhancing effect of PTP-BL.
Tissue Expression Patterns for PTP-BL and  Fas Receptor—A  
Northern blot of total RNA from several mouse tissues was 
used to determine the tissue distribution of both Fas receptor 
and PTP-BL. The obtained patterns are quite distinct (Fig. 6). 
Expression of Fas receptor is very high in  lung and thymus and
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Fig. 6. Tissue expression  for PTP-BL and Fas receptor. North­
ern blot analysis of PTP-BL (upper panel) and Fas receptor {middle 
panel) mRNA expression in different mouse tissues, The lower panel 
shows an ethidium bromide staining as a control for RNA loading,
ubiquitously at a low level in all tissues examined. PTP-BL, on 
the contrary, is expressed a t a high level in lung, kidney, testis, 
stomach, and skin (Fig. 6).
DISCUSSION
I t is now well established th a t one of the functions of PDZ 
motifs is the recruitm ent of proteins via recognition binding of 
their carboxyl-terminal domain (9, 10). The preferred motif in 
this domain has an extremely simple consensus structure (10, 
34). This raises the question how the cell can meet the criteria 
required for high specificity in binding interaction, necessary to 
achieve correct functioning of the cell signaling network. As a 
working hypothesis for the studies presented here, we assumed 
th a t there must be a strong evolutionary preference to conserve 
the optimal interaction avidity between individual PDZ do­
mains and their preferred substrate.
Interestingly, the protein-tyrosine phosphatase PTP-BAS/ 
FAP-1, which contains five PDZ motifs, was found to directly 
associate with the Fas receptor via its second PDZ motif. How­
ever, the carboxyl terminus of the Fas receptor, which is in­
volved in this interaction, is not strongly conserved between 
species (Fig. 1). Furthermore, the amino acids demonstrated to 
be important for the interaction with PTP-BAS (10, 12) have 
been substituted in the mouse Fas receptor. To conserve the 
interaction, the second PDZ motif of the mouse homologue of 
PTP-BAS/FAP-1, PTP-BL, may have adapted to these changes. 
This is not very likely, since this motif is very homologous 
between human (13) and mouse (22) (96% identical) and bovine 
(GenBank™ accession number 915210) (98% identical). Alter­
natively, the PTP-BL PDZ-II may be tolerant in peptide recog­
nition, allowing different peptides to bind. This, however, 
would affect high specificity constraints necessary in signaling 
networks.
Our results show th a t PTP-BL does interact with the human 
Fas receptor, but fails to interact with the mouse Fas receptor. 
This indicates th a t specific peptide recognition is conserved 
between species and th a t changes, as found in the carboxyl 
terminus of the Fas receptor abolishes the interaction. This last 
observation is in line with the tightly defined consensus motif 
for binding to the second PDZ domain of PTP-BAS/FAP-1, 
which was independently found to be iS/TxV/I (10) or iS/TxV/ 
L/I (12). Furthermore, none of the other PDZ motifs of PTP-BL 
does interact with the carboxyl terminus of the mouse Fas 
receptor, indicating th a t PTP-BL does not directly interact 
with the Fas receptor in vivo . This is corroborated by immuno­
précipitation experiments, which failed to detect PTP-BAS/ 
FAP-1 or an approximately 250-kDa protein in the unstimulated 
or stimulated Fas receptor-containing complex (20, 35, 36).
However, any indirect involvement of the tyrosine phospha­
tase PTP-BL in Fas signaling cannot be excluded, although 
even the basal question if tyrosine phosphorylation is involved 
in  modulating Fas signaling is not answered yet. For tyrosine 
kinases as well as tyrosine phosphatases, both stimulatory and 
inhibitory effects on Fas-m ediated apoptosis have been re­
ported. For example, the protein-tyrosine kinase Abl and the 
tyrosine phosphatase PTP-BAS/FAP-1 both were found to in­
hibit the process (16, 37), whereas another cytosolic tyrosine 
phosphatase, the hematopoietic cell phosphatase HCP/SHP-1, 
and the p59fyn kinase seem to potentiate the apoptotic signal 
induced by Fas (38, 39). The involvement of HCP/SHP-1 re­
mains controversial (40), Furtherm ore, a rapid induction of 
tyrosine phosphorylation of multiple cellular proteins upon 
stimulation of Fas-mediated apoptosis is reported (41). This 
phosphorylation as well as the apoptotic process could be 
blocked by inhibitors of protein-tyrosine kinases in a concen­
tration-dependent manner. Findings th a t a Ju rkat cell variant, 
deficient in this elevation of tyrosine phosphorylation upon Fas 
ligation, still does undergo apoptosis are contradictory to these 
findings (42). Furtherm ore, the observed correlation between 
the levels of endogenous PTP-BAS/FAP-1 and resistance to 
Fas-mediated apoptosis in several cell lines (16) is not con­
firmed by others (20). Taken together, the involvement of ty­
rosine phosphorylation in general and certain protein-tyrosine 
kinases and phosphatases in particular in Fas signaling re­
mains controversial. The reported effects may be secondary 
downstream effects and m ight be cell type-specific.
Functional studies using our model system revealed no ob­
vious role for the protein-tyrosine phosphatase PTP-BL in the 
regulation of Fas-mediated apoptosis. A small inhibitory effect 
on Fas-m ediated apoptosis was observed in transformants ex­
pressing hum an Fas receptor. In  contrast, PTP-BL seems to 
enhance apoptosis in mouse Fas receptor expressing transfor­
mants. However, both effects are not dependent upon the ex­
pression level of PTP-BL, since transformants expressing equal 
amounts of Fas receptor on their surface, but expressing dif­
ferent amounts of PTP-BL, behave very similar. Clonal varia­
tions and differences in  the am ount of surface expression of Fas 
receptor for the transform ants w ith and without PTP-BL may 
partially account for the differences observed. Furthermore, 
the small inhibitory effect of PTP-BL on human Fas-mediated 
apoptosis may be caused by its capability to interact with the 
carboxyl term inus of the hum an Fas receptor and thereby 
inhibiting the formation of a functional death-inducing signal­
ing complex ra th er than  its catalytic activity. This effect will 
not occur in the mouse system, because PTP-BL does not in­
teract with the mouse Fas receptor. Nevertheless, no influence 
of PTP-BL expression could be observed after overnight incu­
bation with apoptosis-inducing antibodies, clearly demonstrat­
ing th a t PTP-BL can not (partially) protect from Fas-mediated 
apoptosis.
These results, combined with the different RNA expression 
patterns make an im portant role for PTP-BL in the regulation 
of Fas-mediated apoptosis in mouse very unlikely. In mouse the 
negatively regulatory carboxyl term inus of the Fas receptor 
may bind other, so far unknown, proteins and perhaps in a 
PDZ-mediated fashion. Interestingly, we have observed th a t a 
deletion of the carboxyl-terminal region of human Fas potenti­
ates Fas-induced apoptosis in mouse L929 cells (43). However, 
a similar deletion in mouse Fas did not show any effect.3 Thus, 
the role of the Fas carboxyl term inus in regulating the apo­
ptotic process rem ains unclear. Furthermore, the target mole­
cules for the PTP-BL PDZ motifs are still to be determined and 
will aid in elucidating its biological function.
3 S, Nagata, unpublished observations.
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